Comunicati.net - Comunicati pubblicati - Last Minute Comunicati.net - Comunicati pubblicati - Last Minute Thu, 21 Jun 2018 12:04:33 +0200 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://content.comunicati.net/comunicati/turismo/last_minute/1 COMUNICATO STAMPA - I 10 migliori Campeggi e Villaggi per Famiglie: il Campeggio Villaggio L’Ultima Spiaggia d i Bari Sardo, in Sardegna, vince il premio Family 2018. Presenti strutture di Sardegna, Veneto (2), Friuli Venezia Giulia, Toscana, Marche, Abruzzo, Calabria e Sicilia. Wed, 20 Jun 2018 09:55:47 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/483613.html http://content.comunicati.net/comunicati/turismo/last_minute/483613.html Koobcamp Koobcamp
Buongiorno,
di seguito e in allegato trovate il comunicato stampa "I 10 migliori Campeggi e Villaggi per Famiglie: il Campeggio Villaggio L’Ultima Spiaggia di Bari Sardo, in Sardegna, vince il premio Family 2018", relativo al premio assegnato dal network KoobCamp ai 10 migliori campeggi italiani Family, specializzati nelle vacanze all'aria aperta per le famiglie.

Il premio rientra nell'iniziativa dei Certificati di Eccellenza KoobCamp 2018 (terza edizione) ed è stato assegnato dagli esperti KoobCamp in collaborazione con TrustYou, affermata piattaforma di feedback a livello internazionale, per l'analisi delle recensioni dei turisti sui principali portali di reviews.

Nella Top 10 dei Migliori Campeggi Family 2018, il Campeggio Villaggio L'Ultima Spiaggia a Bari Sardo (NU), in Sardegna, si aggiudica il titolo di vincitore assoluto. 

Presenti le strutture delle seguenti regioni: Sardegna, Veneto (2), Friuli Venezia Giulia, Toscana, Marche, Abruzzo, Calabria e Sicilia.

Fiducioso nel vostro interesse, ringrazio in anticipo per l'eventuale pubblicazione e resto a disposizione per l'invio di materiali aggiuntivi.

Buon lavoro,
Flavio Sartini


COMUNICATO STAMPA

I 10 migliori Campeggi e Villaggi per Famiglie: il Campeggio Villaggio L’Ultima Spiaggia di Bari Sardo, in Sardegna, vince il premio Family 2018

Il network KoobCamp, nell'ambito dei Certificati di Eccellenza 2018, ha selezionato i migliori campeggi e villaggi italiani per le vacanze in famiglia.

 

È il Campeggio Villaggio L’Ultima Spiaggia di Bari Sardo (NU), nella splendida zona dell’Ogliastra in Sardegna, ad aggiudicarsi il titolo di miglior campeggio/villaggio Family 2018, assegnato nell’ambito della terza edizione dei Certificati di Eccellenza KoobCamp. Nella TOP 10 del certificato KoobCamp che premia le migliori strutture en plein air per le vacanze in famiglia, insieme al vincitore della Sardegna, figurano anche campeggi e villaggi in rappresentanza di Veneto (2), Friuli Venezia Giulia, Toscana, Marche, Abruzzo, Calabria e Sicilia.

La vittoria finale del Campeggio Villaggio L’Ultima Spiaggia di Bari Sardo (NU) è il risultato di un’attenta selezione che, nella prima fase, ha portato alla nomina dei 10 migliori Campeggi e Villaggi per le vacanze in famiglia. La selezione, come per gli altri certificati, è stata realizzata dagli esperti del network turistico KoobCamp ( https://www.koobcamp.com/ ) in collaborazione con TrustYou ( https://www.trustyou.com/ ), affermata piattaforma di feedback a livello internazionale per l’analisi delle recensioni dei turisti sui maggiori portali di settore. Ideali per le vacanze di tutta la famiglia, con servizi dedicati sia agli adulti che ai bambini, ecco i 10 migliori Campeggi e Villaggi Family 2018 (in ordine casuale, vincitore escluso):

·         Campeggio Villaggio L'Ultima Spiaggia a Bari Sardo (NU), in Sardegna �“ VINCITORE

·         Altomincio Family Park a Valeggio sul Mincio (VR), in Veneto

·         Villaggio Turistico Internazionale di San Michele al Tagliamento (VE), in Veneto

·         Camping Sabbiadoro a Lignano Sabbiadoro (UD), in Friuli-Venezia Giulia

·         Argentario Camping Village a Orbetello (GR), in Toscana

·         Camping Village Le Capanne a Bibbona (LI), in Toscana

·         Numanablu Family Camping & Resort a Numana (AN), nelle Marche

·         Camping Village Eurcamping a Roseto degli Abruzzi (TE), in Abruzzo

·         Villaggio Il Gabbiano a Ricadi (VV), in Calabria

·         Camping Sabbiadoro ad Avola (SR), in Sicilia

Il premio Family 2018 arriva dopo i Certificati KoobCamp per le categorie Pet Friendly, Glamping, Sport, Wellness, Art City, Camper ed Unusual Accommodations e precede, Aquapark, Restaurant, Wi-Fi e Accessible. I Certificati di Eccellenza KoobCamp, visibili sul portale Campeggi.com ( https://www.campeggi.com/ ) e sugli altri siti del network KoobCamp, rappresentano un premio agli sforzi fatti dalle strutture per andare incontro alle esigenze dei turisti e sono uno strumento al servizio dei campeggiatori per una migliore organizzazione delle vacanze.



--
Flavio Sartini Press Office Manager
areapress@koobcamp.com - www.koobcamp.com/press
Via XXV Aprile, 179/b - 10042 Nichelino - TO - Italy
Tel. +39 011.197.11.053 Mob. +39 347.223.08.07 Fax +39 011.043.27.25
P.Iva: 10628300013
Informativa per i destinatari dei messaggi di posta elettronica

Il contenuto delle e-mail è da ritenersi confidenziale. Pertanto, le informazioni in esse o negli eventuali allegati contenute sono riservate esclusivamente ai destinatari. Persone o soggetti diversi dai destinatari stessi, non sono autorizzate a leggere, copiare, modificare, diffondere il messaggio a terzi. Chi ricevesse una nostra comunicazione per errore non la utilizzi e non la porti a conoscenza di nessuno, ma la elimini dalla sua casella e avvisi il mittente. Inoltre, ai sensi dell’art. 13 D.Lgs 196/2003 e ss.mm.ii e dell'art. 13 del GDPR 679/2016, vi informiamo che il Titolare del trattamento è KOOBCAMP S.R.L., con sede in Corso Duca degli Abruzzi n. 2 - 10128 Torino e che il vostro indirizzo di posta è nei nostri archivi in conseguenza di precedenti comunicazioni intercorse e che sarà da noi utilizzato nel rispetto della volontà e disponibilità degli interessati a ricevere comunicazioni via posta elettronica dalla nostra società. Vi informiamo inoltre che, per esigenze connesse con l'attività operativa, qualsiasi messaggio, sia in uscita che in entrata, potrebbe essere letto da soggetti diversi dal mittente e/o dal destinatario. Nel caso in cui gli interessati desiderassero che il loro indirizzo di posta elettronica venisse rimosso dal nostro archivio, potranno esercitare i diritti previsti dall’art 7 D.Lgs 196/2003 ss.mm.ii. e dagli artt. da 15 a 22 del GDPR 679/2016, inviando una comunicazione all’ indirizzo e-mail:amministrazione@koobcamp.com, PEC: naturalbooking@crpec.it
]]>
Global Breast Cancer Treatment Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 11:25:07 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/481482.html http://content.comunicati.net/comunicati/turismo/last_minute/481482.html SAI SAI Global Breast Cancer Treatment Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

The global breast cancer treatment market is expected to increase with significant CAGR due to increasing prevalence and incidence of breast cancer cases. Rising awareness about breast cancer stages and treatment, government initiatives, and improving healthcare infrastructure are driving the breast cancer treatment market. Moreover, the rise in the healthcare expenditure, increase in the diabetic and obese population, increased spending on medicines, increasing consumption of alcohol and tobacco, and rising female population age of 65 years and above are expected to fuel the breast cancer treatment market over the forecast period. Furthermore, increase in the investments in research and developments, development of targeted drug delivery systems, and advancement in cancer biology & pharmacology might boost the breast cancer treatment market. However, drug development challenges in developing countries, long-term side effects of drugs, high costs associated with drug development, stringent regulatory guidelines, and patent expiry of drugs might hamper the growth of breast cancer treatment market in the forecast years.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

The breast cancer treatment market is segmented based on the treatment mechanism, treatment type, and distribution channel

Based on treatment mechanism, the breast cancer treatment market has been segmented into the following:

·        Local

·        Adjuvant

·        Neoadjuvant

·        Systemic

 

Based on drug class, the breast cancer treatment market has been segmented into the following:

·        Chemotherapy

·        Anthracyclines

·        Antimetabolites

·        Epothilones

·        Taxanes

·        Alkylating agents

·        Hormonal therapy

·        Aromatase inhibitors

·        Selective Oestrogen-receptor modulators

 

Based on the distribution channel, the breast cancer treatment market has been segmented into the following:

·        Hospital Pharmacies

·        Retail Pharmacies

·        Online Pharmacies

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-c654SbFYO64MsOhu

 

Global breast cancer treatment market is in developing stage, owing to increase in the prevalence rate of breast cancer disease. According to World Health Organization, about 2000 new cases in men and approximately 200,000 new breast cancer cases in women are diagnosed. Most of the pharmaceutical companies in breast cancer treatment market are focus on research and development activities, strategic collaborations, acquisitions & mergers, and product launches for the development of their revenue in the breast cancer treatment market. For instance, in March 2017, Novartis has received FDA approval for its drug kisqali (ribociclib, LEE011) used as first-line treatment for the HR+/HER2 metastatic breast cancer along with aromatase inhibitor. Similarly, In September 2013, The U.S. Food and Drug Administration granted the accelerated approval for Perjeta (pertuzumab) used in the treatment of early stage breast cancer treatment before surgery. The innovation of some innovative therapy with better success rate is expected to offer a good opportunity for breast cancer treatment market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-14mlyhjMGhVjZqa3

  

Some of the players in breast cancer treatment market are AstraZeneca (U.K.), GlaxoSmithKline plc (U.K.), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Sanofi (France), Pfizer, Inc (U.S.). Sun Pharmaceutical Industries Ltd (India), Actavis, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Bayer AG (Germany), Teva Pharmaceutical Industries. Ltd. (Israel), Puma Biotechnology, Inc. (U.S.), and OncoGenex Pharmaceuticals Inc. (U.S.) to name a few.

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Global Breast Cancer Treatment Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 11:24:56 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/481481.html http://content.comunicati.net/comunicati/turismo/last_minute/481481.html SAI SAI Global Breast Cancer Treatment Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

The global breast cancer treatment market is expected to increase with significant CAGR due to increasing prevalence and incidence of breast cancer cases. Rising awareness about breast cancer stages and treatment, government initiatives, and improving healthcare infrastructure are driving the breast cancer treatment market. Moreover, the rise in the healthcare expenditure, increase in the diabetic and obese population, increased spending on medicines, increasing consumption of alcohol and tobacco, and rising female population age of 65 years and above are expected to fuel the breast cancer treatment market over the forecast period. Furthermore, increase in the investments in research and developments, development of targeted drug delivery systems, and advancement in cancer biology & pharmacology might boost the breast cancer treatment market. However, drug development challenges in developing countries, long-term side effects of drugs, high costs associated with drug development, stringent regulatory guidelines, and patent expiry of drugs might hamper the growth of breast cancer treatment market in the forecast years.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

The breast cancer treatment market is segmented based on the treatment mechanism, treatment type, and distribution channel

Based on treatment mechanism, the breast cancer treatment market has been segmented into the following:

·        Local

·        Adjuvant

·        Neoadjuvant

·        Systemic

 

Based on drug class, the breast cancer treatment market has been segmented into the following:

·        Chemotherapy

·        Anthracyclines

·        Antimetabolites

·        Epothilones

·        Taxanes

·        Alkylating agents

·        Hormonal therapy

·        Aromatase inhibitors

·        Selective Oestrogen-receptor modulators

 

Based on the distribution channel, the breast cancer treatment market has been segmented into the following:

·        Hospital Pharmacies

·        Retail Pharmacies

·        Online Pharmacies

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-c654SbFYO64MsOhu

 

Global breast cancer treatment market is in developing stage, owing to increase in the prevalence rate of breast cancer disease. According to World Health Organization, about 2000 new cases in men and approximately 200,000 new breast cancer cases in women are diagnosed. Most of the pharmaceutical companies in breast cancer treatment market are focus on research and development activities, strategic collaborations, acquisitions & mergers, and product launches for the development of their revenue in the breast cancer treatment market. For instance, in March 2017, Novartis has received FDA approval for its drug kisqali (ribociclib, LEE011) used as first-line treatment for the HR+/HER2 metastatic breast cancer along with aromatase inhibitor. Similarly, In September 2013, The U.S. Food and Drug Administration granted the accelerated approval for Perjeta (pertuzumab) used in the treatment of early stage breast cancer treatment before surgery. The innovation of some innovative therapy with better success rate is expected to offer a good opportunity for breast cancer treatment market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-breast-cancer-treatment-market/#ulp-14mlyhjMGhVjZqa3

  

Some of the players in breast cancer treatment market are AstraZeneca (U.K.), GlaxoSmithKline plc (U.K.), Eli Lilly and Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Sanofi (France), Pfizer, Inc (U.S.). Sun Pharmaceutical Industries Ltd (India), Actavis, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Bayer AG (Germany), Teva Pharmaceutical Industries. Ltd. (Israel), Puma Biotechnology, Inc. (U.S.), and OncoGenex Pharmaceuticals Inc. (U.S.) to name a few.

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Global Bladder Cancer Treatment Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Fri, 01 Jun 2018 11:12:53 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/481468.html http://content.comunicati.net/comunicati/turismo/last_minute/481468.html SAI SAI Global Bladder Cancer Treatment Market Size, Share, Trends, Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Bladder Cancer Treatment Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Bladder cancer is a disease in which malignant cells are formed in the tissues of the bladder. Symptoms of bladder cancer include blood in the urine, pain with urination and low back pain. There are three types of bladder cancer that begin in the cells in the lining of the bladder. They are named as transitional cell carcinoma, squamous cell carcinoma, and adenocarcinoma.

 

Increase in incidence rate of bladder cancer cases, technological advancements, drug innovations with regard to the treatment of bladder cancer, government initiatives, the rise in aging of the population, and advanced health care services are expected to drive the market for bladder cancer treatment drugs. In addition, the rise in awareness about bladder diseases, their available therapies in the market, and increase in health care expenditure are driving the global market for bladder cancer treatment drugs. However, the rise in a number of patent expirations, asymptomatic nature of the disease, and rise in the use of generic drugs are some of the major factors restraining the revenue growth of the global bladder cancer treatment drugs market over the forecast period.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-bladder-cancer-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

Global bladder cancer treatment market is segmented based on cancer type, drug class, and distribution channel:

 

Based on cancer type, global bladder cancer treatment market is segmented as:

·          

o    Transitional cell bladder cancer

o    Invasive bladder cancer

o    Superficial bladder cancer

o    Squamous cell bladder cancer

o    Other rare types

 

Based on drug class, global bladder cancer treatment market is segmented as:

·          

o    Chemotherapy

·         Alkylating agents

·         Plant alkaloids

·         Taxanes

·         Anti-tumour Antibiotics

·         Anti-metabolites

·         Topoisomerase inhibitors

·          

o    Immunotherapy

·         Tumor-targeting mAbs

·         DC-Based immunotherapy

·         Peptide- and DNA-based anticancer vaccines

·         Immune stimulatory cytokines

·         Immune modulatory mAbs

·         Immuno suppressive metabolism Inhibitors

·         Pattern recognition receptor Agonists

·         Others

 

Based on distribution channel, global bladder cancer treatment market is segmented as:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-bladder-cancer-treatment-market/#ulp-c654SbFYO64MsOhu

 

As per to the National Institute of Health, approximately17,000 women  and  45,000 men for every year are diagnosed with the bladder cancer in U.S. only. Market for bladder cancer is rapidly increasing and it is anticipated to grow rapidly from 2016 to 2022 globally. As per to The American Cancer Society, in 2017, estimated bladder cancers in the United States were 79,030 new cases (about 60,490 in men and 18,540 in women) were diagnosed and about 16,870 deaths from bladder cancer (about 12,240 in men and 4,630 in women).Bladder cancer accounts for about 5% of all new cancers in the US. It is the fourth most common cancer in men, but it is less common in women. In addition, the rise in awareness about bladder cancer and its available treatment options in the market, innovation in drug development, and subsequent technological advancements are expected to drive the market for bladder cancer treatment drugs. Increasing number of mergers and acquisitions, the rise in a number of collaborations and partnerships, new product launches and growing awareness about the availability of bladder cancer treatment drugs are some of the latest trends that have been observed in the market.

 

Global bladder cancer treatment market is segmented into five regions: North America, Europe, Asia Pacific, Latin America and The Middle East & Africa. North America followed by Europe, comprise largest market share for the bladder cancer treatment market due to the availability of advanced health care solutions, increase in the bladder cancer cases, rise in concern about bladder problems and development of health care infrastructure in the region. Asia is expected to show a high growth rate in the bladder cancer treatment drugs market during the forecast period due to rise in significant growth in bladder cancer cases, rise in need for the improved bladder cancer treatments and therapies, increasing awareness on cancer diagnosis. Growing demographics and economies in the developing countries, such as India and China, are anticipated to rise the bladder cancer treatment drugs market in Asia-Pacific region.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-bladder-cancer-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

Some of the players in the global bladder cancer treatment market include AstraZeneca plc (U.K.), Bristol-Myers Squibb (U.S.), Celgene Corporation (U.S.), Eli Lilly and Company (U.S.), Co., F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc.( U.S.), and Sanofi (France)

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Global Anti-Obesity Devices Market Size, Share, Trends, and Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Thu, 31 May 2018 11:11:17 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/481302.html http://content.comunicati.net/comunicati/turismo/last_minute/481302.html SAI SAI Global Anti-Obesity Devices Market Size, Share, Trends, and Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Anti-Obesity Devices Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

The global anti-obesity devices, expected to grow at a significant CAGR due to increase in the prevalence of obesity. According to WHO, obesity has doubled since 2015. In 2014 around 13% of adults aged 18 years or above were obese, and cause of death of approximately 2.8 Mn people annually around the globe. Rising demand for less invasive procedures for obesity treatment has significantly affected the growth of anti-obesity devices market. Similarly, increase in disposable income in developing countries, and recent product approvals from U.S. Food and Drug Administration for new anti-obesity devices are the major factors boosting the growth of anti-obesity devices market. However, the side effects associated with the use of these devices, availability of medications for obesity, and product failure in some cases might hamper the growth of anti-obesity devices market over the forecast period.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-anti-obesity-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Anti-obesity treatment market segmented on the basis of product type, method of deployment, and end user

 

Based on product-type, anti-obesity devices market has been segmented into the following:

·        Gastric bands

·        Electrical stimulation system

·        Gastric balloon system

·        Gastric emptying system

·        Appetite suppressors

 

Based on the method of deployment, anti-obesity devices market has been segmented into the following:

·        Trans-oral

·        Endoscopy

·        Surgery

 

Based on the end user, anti-obesity devices market has been segmented into the following:

·        Hospitals

·        Gastroenterology clinics

·        Ambulatory surgical centres

                                              

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-anti-obesity-devices-market/#ulp-c654SbFYO64MsOhu

 

 

Global anti-obesity devices market is in the nascent stage with local, and international players operating in the anti-obesity devices market. Conventionally, anti-obesity devices are expected to dominate in the obesity treatment market due to the ease of administration and lesser cost, and minimal invasiveness. FDA has approved the various types of anti-obesity devices, which may affect the growth of anti-obesity devices market positively. For instance, In January 2015, FDA has approved the EnteroMedics Inc.’s Vbloc Maestro system intended to treat morbid obesity. Similarly, in February 2011, Allergan got approval for anti-obesity device Lap-band, the adjustable gastric band used in the treatment of obesity. With an increasing number of device approvals, the anti-obesity market is anticipated to have a positive outlook in the forecast period.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-anti-obesity-devices-market/#ulp-14mlyhjMGhVjZqa3

 

Some of the players in anti-obesity devices market are Allergan, Inc. (U.S.), Medtronic. (Covidien PLC) (U.S.), EnteroMedics, Inc (U.S.), Cousin Biotech (France), Surgical IOC (Peters Surgical SAS) (France), PARE Surgical Inc. (U.S.), and GI Dynamics (U.S.) to name a few.

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Global Anti-Obesity Devices Market Size, Share, Trends, and Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024 Thu, 31 May 2018 11:11:15 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/481301.html http://content.comunicati.net/comunicati/turismo/last_minute/481301.html SAI SAI Global Anti-Obesity Devices Market Size, Share, Trends, and Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Global Anti-Obesity Devices Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

The global anti-obesity devices, expected to grow at a significant CAGR due to increase in the prevalence of obesity. According to WHO, obesity has doubled since 2015. In 2014 around 13% of adults aged 18 years or above were obese, and cause of death of approximately 2.8 Mn people annually around the globe. Rising demand for less invasive procedures for obesity treatment has significantly affected the growth of anti-obesity devices market. Similarly, increase in disposable income in developing countries, and recent product approvals from U.S. Food and Drug Administration for new anti-obesity devices are the major factors boosting the growth of anti-obesity devices market. However, the side effects associated with the use of these devices, availability of medications for obesity, and product failure in some cases might hamper the growth of anti-obesity devices market over the forecast period.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-anti-obesity-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Anti-obesity treatment market segmented on the basis of product type, method of deployment, and end user

 

Based on product-type, anti-obesity devices market has been segmented into the following:

·        Gastric bands

·        Electrical stimulation system

·        Gastric balloon system

·        Gastric emptying system

·        Appetite suppressors

 

Based on the method of deployment, anti-obesity devices market has been segmented into the following:

·        Trans-oral

·        Endoscopy

·        Surgery

 

Based on the end user, anti-obesity devices market has been segmented into the following:

·        Hospitals

·        Gastroenterology clinics

·        Ambulatory surgical centres

                                              

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-anti-obesity-devices-market/#ulp-c654SbFYO64MsOhu

 

 

Global anti-obesity devices market is in the nascent stage with local, and international players operating in the anti-obesity devices market. Conventionally, anti-obesity devices are expected to dominate in the obesity treatment market due to the ease of administration and lesser cost, and minimal invasiveness. FDA has approved the various types of anti-obesity devices, which may affect the growth of anti-obesity devices market positively. For instance, In January 2015, FDA has approved the EnteroMedics Inc.’s Vbloc Maestro system intended to treat morbid obesity. Similarly, in February 2011, Allergan got approval for anti-obesity device Lap-band, the adjustable gastric band used in the treatment of obesity. With an increasing number of device approvals, the anti-obesity market is anticipated to have a positive outlook in the forecast period.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-anti-obesity-devices-market/#ulp-14mlyhjMGhVjZqa3

 

Some of the players in anti-obesity devices market are Allergan, Inc. (U.S.), Medtronic. (Covidien PLC) (U.S.), EnteroMedics, Inc (U.S.), Cousin Biotech (France), Surgical IOC (Peters Surgical SAS) (France), PARE Surgical Inc. (U.S.), and GI Dynamics (U.S.) to name a few.

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Greenhouse Irrigation System Market projected to grow with significant CAGR over the forecast period Tue, 29 May 2018 08:50:18 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/480965.html http://content.comunicati.net/comunicati/turismo/last_minute/480965.html sravan sravan Greenhouse Irrigation System Market projected to grow with significant CAGR over the forecast period

 

Overview of the Greenhouse Irrigation System Market

It is basically the irrigation system mostly used in the greenhouses. A greenhouse is basically a structure made of either plastic or glass. Due to use of plastic/glass a controlled environment can be maintained within a greenhouse irrespective of the season. Due to such controlled environment, crop yield is better and the overall water requirement of plants is greatly reduced in a greenhouse. Irrigation systems like drip irrigation, boom irrigation, sprinkle irrigation and micro sprinkle are few irrigation systems that can be used for a green house. Due to smaller area drip irrigation systems and micro sprinkle systems are more popular in greenhouses.

Greenhouse Irrigation System Market – Drivers Vs Constraints

Rapidly increasing population, developments, water scarcity, shrinking farming area and unfavourable climatic conditions are the main factors responsible for driving growth to the greenhouse irrigation system market. In addition to this better crop yield from greenhouses and government initiatives to make greenhouses popular will boost the market further. Also, increasing popularity of vertical or rooftop farming in developed nations will propel the market.

On contrary, unawareness about greenhouses in underdeveloped regions, high setting up and maintenance costs for greenhouses will continue to act like constraints to the growth of greenhouse irrigation system market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-greenhouse-irrigation-system-market/#ulp-4H8Z4LpNMLEuOnnx

 

Global Greenhouse Irrigation System Market – Segmentation

Greenhouse irrigation system can be segmented on the basis of irrigation type, product type and application.

On the basis of irrigation type, the market can be segmented as below:-

·         Boom irrigation

·         Drip irrigation

·         Micro sprinkler irrigation

 

On the basis of product type, the market can be segmented as below:-

 

·         Drip line and drip tape

·         Micro-sprinklers

·         Hose

·         Spinners and sprays

·         Regulators

·         Valves

·         Others

 

On the basis of application, the market can be segmented as below:-

 

·         Fruits and vegetables

·         Flowers and ornamentals

·         Other

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-greenhouse-irrigation-system-market/#ulp-c654SbFYO64MsOhu

 

 Analysis of the Greenhouse Irrigation System Market Based on Regions

 

On the basis of regions, the greenhouse irrigation system can be divided into five important regions. They are:-

 

·         North America

·         Latin America

·         Europe

·         Asia-Pacific

·         Middle East and Africa

 

Main growth drivers for North American region are - popularity of vertical or rooftop farming, a change in the climatic conditions in USA, introduction of novel irrigation systems etc.

 

In Europe, growth driving factors are - increase in agriculture activities in few European countries like UK, Germany and Russia; decrease in farming land area; more and more adoption of greenhouse farming etc.

 

In Asia-Pacific region, factors like increasing population and pressure built to meet this growing food need, rapid urbanization and growing popularity of greenhouse farming in this region will boost the growth for the greenhouse irrigation system.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-greenhouse-irrigation-system-market/#ulp-14mlyhjMGhVjZqa3

 

Greenhouse Irrigation System Market – Key Players

 

Names of few important players in the greenhouse irrigation system market are as provided below:-

 

·         Rivulis Irrigation (Israel)

·         Nelson Irrigation Corporation (U.S.)

·         Irritec S.p.A. (Italy)

·         EPC Industries Limited (India)

·         The Toro Company (U.S.)

·         Netafim Ltd. (Israel)

·         Valmont Industries, Inc. (U.S.)

·         Rain Bird Corporation (U.S.)

·         Lindsay Corporation (U.S.)

·         Jain Irrigation Systems Ltd. (India)

 

Global Greenhouse Irrigation System Market- Key Developments

 

·         April, 2017 – Introduction of LFX300 low flow sprinkler by Rain Bird.

·         August, 2017 – Mexichem became 80% stakeholder of Netafilm drip irrigation pioneer in order to strength its drip irrigation range.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-greenhouse-irrigation-system-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

 

]]>
Fertigation and Chemigation Market projected to grow with significant CAGR over the forecast period Tue, 29 May 2018 08:49:50 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/480963.html http://content.comunicati.net/comunicati/turismo/last_minute/480963.html sravan sravan Fertigation and Chemigation Market projected to grow with significant CAGR over the forecast period

 

Overview of Fertigation and Chemigation Market

The process of introducing fertilizers or other water soluble agricultural products to the plants through their irrigation system is called fertigation. Similarly, introduction of chemicals like herbicides, fungicides, pesticides etc through irrigation system is called chemigation. There are numerous benefits of fertigation over conventional methods like – optimal use of fertilizers and other chemicals, better nutrition intake by plants, lesser soil pollution etc.

Drivers and Constraints for the Fertigation and Chemigation Market

Drivers: - Demand for quality food for the increasing population, growing need for plant nutrients, loss of nutrients due to leaching process and a continuous demand for high and better quality yield from crops.

Also, more and more adoption of modern agricultural practices will drive growth for the fertigation and chemigation market.

Constraints: - High cost of the product, strict regulatory framework for the chemigation product approval, difficulty in deciding the correct dose for application etc will continue to restrict the growth for the fertigation and chemigation market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/fertigation-and-chemigation-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Segmentation of the Fertigation and Chemigation Market

The fertigation and chemigation market can be segmented on the basis of product type, crop type, mode of application and type of irrigation system used.

On the basis of the product type, the market can be segmented as below:-

·         Herbicides

·         Fungicides

·         Insecticides

·         Fertilizers

 

On the basis of the crop type, the market can be segmented as below:-

 

·         Plantation Crops

·         Field Crops

·         Forage and Turf Grasses

·         Orchard Crops

 

On the basis of the mode of application, the market can be segmented as below:-

 

·         Landscape Irrigation

·         Agriculture Irrigation

·         Greenhouse Irrigation

 

On the basis of the irrigation system used, the market can be segmented as below:-

 

·         Drip Irrigation

·         Sprinkler Irrigation

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/fertigation-and-chemigation-market/#ulp-c654SbFYO64MsOhu

 

Analysis of the Fertigation and Chemigation Market Based on Regions

 

On the basis of the geography, the fertigation and chemigation market can be divided into five important regions. They are:-

 

·         North America

·         Latin America

·         Europe

·         Asia-Pacific

·         Middle East and Africa

 

Among all the regions, the North American region is likely to show a significant growth in the forecasted period mainly due to factors like- rising population demanding for high quality food products, more and more adoption of advanced agricultural practices, rising popularity of fertigation and chemigation in the region, availability of novel chemigation products in the region etc.

 

Similarly, in Europe, the growth drivers are – increased agricultural activities in the region, adoption of advanced agricultural practices, more R & D activities to introduce newer products in the market etc.

 

Fertigation and chemigation processes are very new to the Asia-Pacific region but, still the scope for market growth is good due to factors like – agriculture being the primary activity of the major countries in this region, availability of irrigation systems and adoption of advanced agricultural practices.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/fertigation-and-chemigation-market/#ulp-14mlyhjMGhVjZqa3

 

 

Key Players in the Fertigation and Chemigation Market

 

Names of few key players in the fertigation and chemigation market are provided below:-

 

·         Rivulis Irrigation (Israel)

·         The Toro Company (U.S.)

·         Valmont Industries, Inc. (U.S.)

·         Jain Irrigation Systems Ltd. (India)

·         T-L Irrigation Co. (U.S.)

·         Lindsay Corporation (U.S.)

·         EPC Industrie Limited (India)

·         Nelson Irrigation Corporation (U.S.)

·         Netafim (Israel)

·         Rain Bird Corporation (U.S.)

 

Mergers and acquisitions, collaborations, and new product development are the strategies being adopted by the major players.

 

Key developments in the Fertigation and Chemigation Market

 

·         October, 2017 – Acquisition of Agri-Valley Irrigation, Inc. and design and Construction, Inc. by Jain Irrigation Systems Limited to develop a fertigation process for better yield.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/fertigation-and-chemigation-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Bioinsecticides Market projected to grow with significant CAGR over the forecast period Tue, 29 May 2018 08:49:38 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/480962.html http://content.comunicati.net/comunicati/turismo/last_minute/480962.html sravan sravan Bioinsecticides Market projected to grow with significant CAGR over the forecast period

 

Overview of the Bioinsecticides Market

Bioinsecticides are substances derived from naturally occurring microorganisms such as fungi, bacteria, viruses etc. They can prevent the unwanted growth of the pests which can otherwise impact the overall development of plants. Although, action of bioinsecticides is slow but they can prevent the outburst of harmful insects and disease carrying living organisms such as spider, ticks and rats. Action of these bioinsecticides is also decided by soil pH, optimum temperature, and humidity.

Constraints and Drivers of the Bioinsecticides Market

The growth drivers for bioinsecticides market are: - frequent plant diseases due to insects; growing awareness regarding bad impact of synthetic insecticides on our environment; mutation in natural characteristics of flora; soil infertility due to soil pollution; ease to develop bioinsecticides through culturing and their cost effectiveness etc.

Also, factors like government initiatives to encourage adoption of eco-friendly agriculture practices, growing demand for high quality nutritious food and launch of newer bioinsecticides in the market will further boost the growth of bioinsecticides market.

On contrary, factors like short shelf life of bioinsecticides and their slow action mode, unfavourable regulatory policies regarding usage of pesticides etc will restrict the growth of bioinsecticides market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/bioinsecticides-market/#ulp-4H8Z4LpNMLEuOnnx

 

Bioinsecticides Market – Market Segmentation

The global bioinsecticides market can be broadly segmented on the basis of type of insecticides, mode of application, action mechanism, formulation type and crop type.

On the basis of insecticides type, the bioinsecticides market can be segmented as below:-

·         Beauveria Bassiana

·         Bacillus Thruingiensis

·         Metarhizium Anisopliae

·         Verticillium Lecanii

 

On the basis of the mode of application, the bioinsecticides market can be segmented as below:-

·         Seed Treatment

·         Foliar Spray

·         Soil Treatment

·         Post-harvest

 

On the basis of the action mechanism, the bioinsecticides market can be segmented as below:-

 

·         Anti-feeding

·         Mating disruption

·         Desiccation

·         Suffocation

On the basis of the formulation type, the bioinsecticides market can be segmented as below:-

 

·         Solid bioinsecticides

·         Liquid bioinsecticides

 

On the basis of the crop type, the bioinsecticides market can be segmented as below:-

 

·         Vegetables and fruits

·         Cereals and grains

·         Oilseeds and pulses

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/bioinsecticides-market/#ulp-c654SbFYO64MsOhu

 

Analysis of the Bioinsecticides Market Based on Regions

 

On the basis of geography, the bioinsecticides market can be divided into five important regions. They are:-

 

·         North America

·         Latin America

·         Europe

·         Asia-Pacific

·         Middle East and Africa

 

North America is likely to show a significant growth in the projected period, mostly due to factors like – adoption of eco-friendly and organic farming practices; increase in production of fruits and vegetables; more R & D activities and launch of newer products in the market etc.

 

Similarly in Europe, the growth factors are high availability and low cost of bioinsecticides; popularity of eco-friendly agricultural practices etc.

 

Again for Asia-Pacific region, growth drivers are – high dependency on agriculture; low cost of bioinsecticides and rising awareness regarding the benefits of using bioinsecticides.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/bioinsecticides-market/#ulp-14mlyhjMGhVjZqa3

 

Bioinsecticides Market – key Players

 

Few of the key players in the bioinsecticides market are listed below:-

 

·         Novozymes A/S (Denmark)

·         BASF SE (Germany)

·         Bayer CropScience AG (Germany)

·         The Dow Chemical Company (U.S.)

·         Marrone Bio Innovations Inc. (U.S.)

·         Syngenta AG (Switzerland)

·         Valent BioSciences Corporation (U.S.)

·         Koppert B.V. (Netherlands)

 

Bioinsecticides Market – key Developments

 

·         May, 2017 –agreement between Marrone Bio Innovations and Agri-Star for the distribution of bioinsecticides Venerate and Grandevo in Mexico.

·         July, 2016 – Mexico regulatory authority approved Grandevo and Venerate, bioinsecticide products by Marrone Bio Innovations.

·         January, 2016 – Acquisition of Labortorio farroupilha by Lallemand in order to expand its business in Latin America.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/bioinsecticides-market/

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

]]>
Noleggia il tuo camper Mon, 28 May 2018 10:15:53 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/480848.html http://content.comunicati.net/comunicati/turismo/last_minute/480848.html letizia WD web design letizia WD web design Noleggia il tuo camper per le tue vacanze.

Noleggia il tuo camper

Questa estate è il momento di approfittarne per noleggiare un camper e partire alla scoperta di nuove mete e nuove avventure!

Muoversi liberamente; cambiare programma senza troppe limitazioni; non doversi sobbarcare la ricerca di alberghi e strutture che alla fine non soddisfano a pieno le nostre esigenze… sono solo alcuni dei grandi vantaggi del viaggio in camper.

La possibilità di ricreare l’ambiente familiare in cui siamo più a nostro agio è un privilegio che Florence Camper è in grado di darvi con il servizio di noleggio.

L’unica cosa che vi resta da fare è scegliere la meta!

Allora cosa aspetti! Ogni occasione è buona per noleggiare un camper e partire verso nuove avventure.


Forse ancora non sapremo con certezza quale sarà la destinazione. Ma sappiamo bene che viaggiare a bordo di un camper, consente di staccare un po’ la spina con tutte le comodità di casa. Per ritrovare un po’ di calma; recuperare le energie; specialmente in questo periodo dell’anno.

Quindi quello che vi resta da fare è venire a noleggiarlo da noi di Florence Camper!

Buon viaggio a tutti e buone vacanze!

]]>
Noleggia il tuo camper Mon, 28 May 2018 10:15:40 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/480847.html http://content.comunicati.net/comunicati/turismo/last_minute/480847.html letizia WD web design letizia WD web design Noleggia il tuo camper per le tue vacanze.

Noleggia il tuo camper

Questa estate è il momento di approfittarne per noleggiare un camper e partire alla scoperta di nuove mete e nuove avventure!

Muoversi liberamente; cambiare programma senza troppe limitazioni; non doversi sobbarcare la ricerca di alberghi e strutture che alla fine non soddisfano a pieno le nostre esigenze… sono solo alcuni dei grandi vantaggi del viaggio in camper.

La possibilità di ricreare l’ambiente familiare in cui siamo più a nostro agio è un privilegio che Florence Camper è in grado di darvi con il servizio di noleggio.

L’unica cosa che vi resta da fare è scegliere la meta!

Allora cosa aspetti! Ogni occasione è buona per noleggiare un camper e partire verso nuove avventure.


Forse ancora non sapremo con certezza quale sarà la destinazione. Ma sappiamo bene che viaggiare a bordo di un camper, consente di staccare un po’ la spina con tutte le comodità di casa. Per ritrovare un po’ di calma; recuperare le energie; specialmente in questo periodo dell’anno.

Quindi quello che vi resta da fare è venire a noleggiarlo da noi di Florence Camper!

Buon viaggio a tutti e buone vacanze!

]]>
Global Dermal Fillers Market was Valued at US$ 3.2 Bn in 2017 Thu, 24 May 2018 14:21:25 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/480536.html http://content.comunicati.net/comunicati/turismo/last_minute/480536.html sravan sravan The Global Dermal Fillers Market was valued around US$ 3.2 Bn by 2017 and growing at a significant CAGR over six years forecast period 2018-2023 owing to increase in the incidence of cosmetic skin issues and awareness among young population

 

Precision Business Insights (PBI) in its report titled “Global Dermal Fillers Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023” assesses the market performance over forecast period (2018-2023). The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

 

The global dermal fillers market was valued at US$ 3.2 Bn in 2017 and growing at a significant CAGR over the forecast period owing to increase in the number patients with different cosmetic skin issues like deep lines, wrinkles and scars around the globe. Additionally, rise in number of geriatric population, rise in preference for minimally invasive or non-invasive surgical procedures, and fast and ease of treatment are anticipated to propel the global dermal fillers market. However, high cost for the dermal fillers procedure and post-procedure complications are expected to hinder the growth of global dermal fillers market over forecast years.

 

Global dermal fillers market segmented on the basis of product type, ingredient type, distribution channel, and region

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-4H8Z4LpNMLEuOnnx

 

Absorbable dermal fillers accounted for higher revenue share

 

Based on product type, global dermal fillers market segmented into absorbable dermal fillers and non-absorbable dermal fillers. Absorbable dermal fillers market accounted for larger revenue share in 2017 and projected to dominate over the forecast period owing to growing adoption by patients and its safety profile. Moreover, absorbable dermal fillers segment projected exhibit lucrative growth, which is mainly attributed to non-invasive or minimally invasive treatment procedure and low cost of the treatment.

North America leads the Global Dermal Fillers market

 

PBI’s global dermal fillers market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2012-2017 and the same trend is projected to follow over 2018-2023 owing to increase in the preference for non-invasive aesthetic procedures, rise in geriatric population, and increase in disposable income.

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-c654SbFYO64MsOhu

 

Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

 

Global dermal fillers market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance. In 2015, Allergan plc, received approval from the U.S.FDA approval to market its juvederm ultra XC injection used for lip augmentation in adults over the age of 21

 

Key player’s profiles in the report are Galderma (Nestle) (Switzerland), MERZ PHARMA GMBH & CO. KGAA (Germany), and Allergan plc (Ireland)

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-14mlyhjMGhVjZqa3

 

Detailed Segmentation

 

By Product Type

o   Absorbable Dermal Fillers

o   Non-Absorbable Dermal Fillers

By Ingredient Type

o   Hyaluronic Acid (HLA)

o   Poly-L-Lactic Acid (PLA)

o   Calcium Hydroxylapatite (CaH)

o   Polymethylmethacrylate (PMMA)

o   Collagen

o   Others

By Distribution Channel

o   Retail Pharmacies

o   Beauty Clinics

o   Online Pharmacies

Geography

 

o     North America

·         U.S

·         Canada

o     Europe

·         Germany

·         France

·         U.K

·         Italy

·         Spain

·         Russia

·         Poland

·         Rest of Europe

o     Asia-Pacific

·         Japan

·         China

·         India

·         Australia & New Zealand

·         ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)

·         South Korea

·         Rest of Asia-Pacific

o     Latin America

·         Brazil

·         Mexico

·         Argentina

·         Venezuela

·         Rest of Latin America

o     Middle East and Africa (MEA)

·         Gulf Cooperation Council (GCC) Countries

·         Israel

·         South Africa

·         Rest of MEA

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

]]>
Nursing Care Services Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024 Thu, 24 May 2018 09:15:04 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/480470.html http://content.comunicati.net/comunicati/turismo/last_minute/480470.html sravan sravan Nursing Care Services Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Nursing Care Services Market: By Type of Connectivity (Connected to assisted living community, Connected to hospital, Connected to assisted living community and hospital, Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global nursing care services market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Nursing Care Services Market

Nursing care refers to autonomous or collaborative care of individuals of all group, families, communities, by skilled nurses. Nurses are trained to promote the health and prevent various diseases. Trained nurses provide assistance to patients in medical procedures and responsible for giving treatment and medicines. Nursing care approaches of personalized care with more convenience, safety, and comfort.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/nursing-care-services-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Dynamics: Nursing Care Services Market

Increase in number of geriatric population coupled with rise in prevalence of various diseases such as Alzheimer’s disease and dementia are the key factors drive the global nursing care services market. Moreover, rise in persons with disabilities, high disposable income in developed countries, and collaboration between the insurance companies are expected to fuel the nursing care services market over the forecast years. However, high cost of services, low cost of service acceptance in underdeveloped countries, lack of reimbursement services are expected to restrain the growth of global nursing care services market over the forecast period.

 

Market Scope: Nursing Care Services Market

Nursing care services market is segmented on the basis of type of connectivity

Based on the type of connectivity, nursing care services market is segmented into the following:

·         Connected to assisted living community

·         Connected to hospital

·         Connected to assisted living community and hospital

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/nursing-care-services-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Nursing Care Services Market

Geographically, global nursing care services market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America nursing care services market has a lucrative growth attributed to increase in the prevalence of neurodegenerative disorders such as Alzheimer’s and dementia, favorable reimbursement policies, and rise in disposable income are expected to boost the market. Europe nursing care services market has a prominent share attributed to increase in the workforce results to rise in demand for nursing services, rise in number of hospitals, and increase in healthcare expenditure witnessed to propel the market. Asia Pacific nursing care services market is anticipated to offer lucrative opportunities due to increase in geriatric persons in India, China, and Japan, increase in medical tourism in Asia Pacific countries, and increase in the healthcare expenditure in forecast years.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/nursing-care-services-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Nursing Care Services Market

Some of the players in the global nursing care services market include:

·         Genesis Healthcare (U.S.)

·         Lincare Holdings, Inc. (U.S.)

·         Vitas Healthcare (U.S.)

·         Sunrise Senior Living Inc. (U.S.)

·         Apria Healthcare Group Inc. (U.S.)

·         HCR Manor Care, Inc. (U.S.)

·         Kindred Healthcare, Inc. (U.S.)

·         Brookdale Senior Living (U.S.)

·         Extendicare, Inc. (Canada)

·         Golden Living (U.S.)

·         IMMAC Group (Germany)

 

Notable Market Developments: Nursing Care Services Market

·         In December 2017, IMMAC Group acquired Beechfield Care for strengthening of its presence in Europe

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/nursing-care-services-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Global psoriasis treatment market Size 2013-2017 | Forecast 2018-2024 Tue, 22 May 2018 12:27:35 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/480193.html http://content.comunicati.net/comunicati/turismo/last_minute/480193.html sravan sravan Global psoriasis treatment market Size 2013-2017 | Forecast 2018-2024

 

Growing market for Psoriasis Treatment

Global psoriasis treatment market: Psoriasis is a chronic autoimmune disease characterized by abnormal growth of the skin cells. It forms skin patches above the skin and it is not contagious. Psoriasis skin patches are red and itchy. There are different types of psoriasis namely guttate psoriasis, plaque psoriasis, pustular psoriasis, erythrodermic psoriasis and inverse psoriasis. Plaque psoriasis is common and constitutes about 90% of psoriasis cases. The diagnosis of psoriasis is typically made by obtaining information from the physical examination of the skin, medical history, and relevant family health history. Psoriasis affects skin over the elbows, knees, and scalp and is often itchy. Although any area may be involved, it tends to be more common at sites of friction, scratching, or abrasion. Currently, there was no cure for psoriasis. However, treatment is focused on curing the symptoms. Treatment may include steroid creams, vitamin D3 cream, UV light, and Immunosuppressant.

 

Global psoriasis treatment market is driven by increase in smoking and alcohol consumption trends globally. Increased spending on medicines and escalating health care expenditure are the key growth drivers of the market. Psoriasis treatment mainly treated by topical agents only. The recent launch of systemic products into the market expected to drive the growth of the market. However, high cost of the drugs and side-effects associated with the existing medication for psoriasis are expected to hamper the psoriasis treatment market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-psoriasis-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

The Psoriasis treatment market is divided into following categories:

1.      Drug class

·         TNF Inhibitors

·         Vitamin D Analogues

·         Interleukin Blockers

·         Topical Corticosteroids

·         Monoclonal Antibodies

·         Others

 

2.     Type of Psoriasis

·         Plaque Psoriasis

·         Guttate Psoriasis

·         Flexural Psoriasis

·         Inverse Psoriasis

·         Psoriatic Psoriasis

 

3.     Route of administration

·         Oral

·         Topical

·         Parenteral

4.      End-users

Hospital pharmacies, retail pharmacies and online pharmacies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-psoriasis-treatment-market/#ulp-c654SbFYO64MsOhu

 

And lastly on the basis of geographical regions, global psoriasis treatment market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America holds the largest market in the global psoriasis treatment market due to high prevalence of the disease. According to American Academy of Dermatology, approximately 7.5 million people in the United States have Psoriasis. In Europe, the psoriasis treatment market is expected to grow at significant rate due to factors such as increased prevalence and growing awareness about skin diseases and recent launch of biosimilars such as elerzi, amzevita, etc. In Asia-Pacific region, India and China are expected to be fastest growing market due to developing infrastructure and rapid growth in awareness and available treatment options for psoriasis.

 

Some of the key market players in global psoriasis treatment market include Amgen Inc. (U.S), Eli Lilly and Company(U.S), Novartis AG (Switzerland), Merck & Co., Inc. (U.S), Johnson & Johnson Services, Inc., (U.S) Pfizer, Inc. (U.S), AstraZeneca (U.K), AbbVie Inc. (U.S), LEO Pharma A/S (Denmark) and Biogen (U.S) to name a few. In 2017, Janssen Biotech, Inc.’s Tremfya (Guselkumab) approved by USFDA for the treatment of adults living with moderate to severe plaque psoriasis. Also in 2017, USFDA approved Siliq (Brodalumab) injection for the treatment of adult patients with moderate-to-severe plaque psoriasis. This drug was developed by Valeant Pharmaceuticals by partnering with AstraZeneca.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-psoriasis-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

 

Psoriasis treatment market is expected to show significant growth rate owing to prevalence rates and severity of the disease. According to World Health Organization (WHO), 1.3%-34.7% of psoriasis patients develop chronic psoriatic arthritis, which may lead to joint deformations and disability. World Health Organization (WHO) also predicts that psoriasis affects about 100 million people with prevalence rates of 0.09% to 11.43% in different countries. The most common type of psoriasis is plaque psoriasis, affecting 90% of all psoriasis cases. Market players are focusing on R&D to develop new drugs and treatments for psoriasis. The market has a handful of drugs and dominated by generics and biologics. Market players heavily influencing the treatment decisions. Due to the entry of biosimilar into the market, there is availability of cheaper drugs to treat psoriasis and it leading to increased availability and increase market size.  

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-psoriasis-treatment-market/

 

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

 

]]>
Cancer gene therapy market Size 2013-2017 | Forecast 2018-2024 Tue, 22 May 2018 09:11:45 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/480147.html http://content.comunicati.net/comunicati/turismo/last_minute/480147.html sravan sravan Cancer gene therapy market Size 2013-2017 | Forecast 2018-2024

 

Cancer gene therapy is a process that treats cancers by inserting therapeutic DNA into the patient. Cancer gene therapy is gaining popularity as a result of its success rate in preclinical and clinical trial stages. The most common technique for cancer gene therapy involves replacing a mutated gene that is causing cancer with a healthy copy of the gene. A new technique that is being introduced to cancer gene therapy market involves insertion of new genes into the body that would help to fight against tumor cells.

 

Globally, rising cancer prevalence will increase demand for gene therapy as the effective personalized treatment choice. Various factors, such as the increase in the prevalence of cancer, rising government initiatives, increase in funding from various government and non-government organizations, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment, lack of reimbursement policies for advanced gene therapy methods are restraining the growth of the global market for cancer gene therapy.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-cancer-gene-therapy-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

The global cancer gene therapy market is divided into the following categories:

1.      Type

·         Gene Induced Immunotherapy

o    Tumour Antigen Gene Delivery

o    Cytokine Gene Delivery

·         Oncolytic Virotherapy

o    Adenoviruses

o    Adeno Associated Virus

o    Lentiviruses

o    Alpha Virus

o    Retrovirus

o    Herpes Simplex Virus

o    Vaccinia virus

o    Simian Virus

·         Gene Transfer/ Gene Replacement

·         Electroporation

·         Magnetofection

·         Naked / Plasmid Vectors

·         Gene Gun

·         Sonoporation

2.     Therapy

·         Retroviral Therapy

·         Adenoviral Therapy

3.     End-users

Hospitals, Oncology institutes, Biotechnological companies and Clinical Research Labs.

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-cancer-gene-therapy-market/#ulp-c654SbFYO64MsOhu

 

And lastly, on the basis of geographical regions, the cancer gene therapy is divided into North America, Europe, Latin America, Asia- Pacific and the Middle East and Africa. North America leads the global cancer gene therapy market owing to the large pool of aging population and advancements in technology high investments in R & D activities along with the government support will boost industry demand. The U.K. market is anticipated to grow rapidly over the forecast period due to the rising occurrence of cancer along with the increase in acceptance of gene technology. Asia-Pacific is expected to witness high growth in cancer gene therapy market, due to increase in government initiatives, rising economy, and improvement in healthcare infrastructure in the region. Some of the key driving forces for cancer gene therapy market in emerging countries are increasing R&D investment, a large pool of patients and rising government funding. Some of the major companies operating in the global cancer gene therapy market are Urigen Pharmaceuticals Inc. (U.S), GenVec.Inc (U.S), Oxford BioMedica (U.K), Vical (U.S), ANI Pharmaceuticals, Inc. (U.S), and Genzyme Corporation (U.S). Novartis AG (Switzerland), and Cell Medica (U.K.). In 2017, Novartis received USFDA Oncologic Drugs Advisory Committee (ODAC) recommended approval of CTL019, an investigational chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of relapsed or refractory pediatric and young adult patients with B-cell acute lymphoblastic leukemia. And in same year, Cell Medica acquired the Catapult Therapy TCR Limited, a subsidiary of Cell and Gene Therapy Catapult (CGT Catapult), and the initiation of a collaboration to establish cell therapy manufacturing for Cell Medica at CGT Catapult’s GMP manufacturing facility in Stevenage, UK. While back in 2013, BioSante Pharmaceuticals, Inc. completed the merger of its wholly-owned subsidiary with and into ANIP Acquisition Company, ANI Pharmaceuticals, Inc.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-cancer-gene-therapy-market/#ulp-14mlyhjMGhVjZqa3

 

 

Global cancer gene therapy market is highly fragmented with small biotech firms holding a chunk of the overall industry share. Major industry participants adopting various strategies to retaining their market positions such as the development of advanced technologies, maintaining a strong intellectual property, strategic collaborations, and joint ventures adopted by in the global cancer gene therapy. As per WHO, cancer incidence is projected to rise by 50% to reach 15million by the end of this decade. This alarming increase in the number of patients and side effects associated with various chemotherapy drugs entails to a potential treatment approach addressing the growing global burden of the cancers. Small biotech firms dominate the global cancer gene therapy market than the bigger players. The players are constantly engaged in R&D in order to develop novel methods to treat various life-threatening diseases. Increased in the adoption of emerging genomic technologies such as Next Generation Sequencing (NGS) and high-density microarray coupled with favorable government initiatives will fuel global cancer gene therapy market. For instance, CDC supports nationwide screening programs for control of breast, cervical and colorectal cancer among low-income women with little or no health insurance.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-cancer-gene-therapy-market

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

 

]]>
Global Needle Free Drug Delivery Market - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024 Mon, 21 May 2018 09:02:08 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/479967.html http://content.comunicati.net/comunicati/turismo/last_minute/479967.html sravan sravan Global Needle Free Drug Delivery Market - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Needle Free Drug Delivery Market: By Technology (Jet injectors, Inhaler Technology, Novel Needle Free Technologies, and Transdermal Patch Technology), By Site of Delivery (Intra Dermal Injectors, Intramuscular Injectors, and Subcutaneous Injectors), By Applications (Pain Management, Insulin Delivery, Vaccine Delivery, and Others), By Distribution Channel (Hospitals, Clinics, and Others), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global needle free drug delivery market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Needle Free Drug Delivery Market

Needle free drug delivery devices are the medical devices that deliver the drug through the skin using the forces such as shock waves, pressurized gas or electrophoresis and by Lorentz which propels the drug through the skin which virtually nullify the use of the hypodermic needles. Large number of the patients opting for self-administration of drugs which would be possible using the needle free drug delivery devices. The adoption of the needle free drug delivery devices helps in reducing the healthcare expenses to the patients.

 

Market Dynamics: Needle Free Drug Delivery Market

Increase in the prevalence of chronic diseases such as hepatitis B, hepatitis C, AIDS etc. which drives the extensive use of injections and in turn helps in the needle free drug delivery market revenue growth. The growing necessity of self-administration and a significant growth of the geriatric population adding fuel for the growth of the needle free drug delivery market. The ease of administration and pain-free drug delivery and increasing focus on the portable delivery devices has boosted the market growth. However, the restricted use of the needle-free injection systems may hamper the growth of the needle free drug delivery market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/needle-free-drug-delivery-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Needle Free Drug Delivery Market

Needle free drug delivery market is segmented based on the technology, site of delivery, applications, and distribution channel

Based on the technology, the market is segmented into the following:

·         Jet Injectors

·         Inhaler Technology

·         Novel Needle Free Technologies

·         Transdermal Patch Technology

Based on the site of delivery, the market is segmented into the following:

·         Intradermal Injectors

·         Intramuscular Injectors

·         Subcutaneous Injectors

Based on the applications, the market is segmented into the following:

·         Pain Management

·         Insulin Delivery

·         Vaccine Delivery

·         Others

Based on the distribution channel, the market is segmented into the following:

·         Hospitals

·         Clinics

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/needle-free-drug-delivery-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Needle Free Drug Delivery Market

Geographically, global needle free drug delivery market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America needle free drug delivery market is accounted for significant owing to increase in the prevalence of chronic disorders. The adoption of the modern treatments is anticipated to drive the growth of the free drug delivery market. The Asia Pacific is expected to grow faster rate over the forecast period owing to the growing prevalence of chronic diseases and favorable patient demographics.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/needle-free-drug-delivery-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Needle Free Drug Delivery Market

Some of the players in the global needle free drug delivery market include:

·         Inovio Pharmaceuticals, Inc.(U.S)

·         3M Pharmaceuticals (U.S)

·         Antares Pharma, Inc. (U.S)

·         Crossject SA (France)

·         Becton Dickinson and Company (U.S)

·         MedImmune, Inc. (U.S)

·         Optinose, Inc. (U.S)

·         PharmaJet (U.S)

Notable Market Developments: Needle Free Drug Delivery Market

Ø  In February 2017, PharmaJet and Genexine collaborate on DNA vaccine development and commercialization of DNA vaccines for human applications using the PharmaJet needle-free injection systems

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/needle-free-drug-delivery-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Global Needle Free Drug Delivery Market - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024 Mon, 21 May 2018 09:02:06 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/479966.html http://content.comunicati.net/comunicati/turismo/last_minute/479966.html sravan sravan Global Needle Free Drug Delivery Market - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Needle Free Drug Delivery Market: By Technology (Jet injectors, Inhaler Technology, Novel Needle Free Technologies, and Transdermal Patch Technology), By Site of Delivery (Intra Dermal Injectors, Intramuscular Injectors, and Subcutaneous Injectors), By Applications (Pain Management, Insulin Delivery, Vaccine Delivery, and Others), By Distribution Channel (Hospitals, Clinics, and Others), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global needle free drug delivery market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Needle Free Drug Delivery Market

Needle free drug delivery devices are the medical devices that deliver the drug through the skin using the forces such as shock waves, pressurized gas or electrophoresis and by Lorentz which propels the drug through the skin which virtually nullify the use of the hypodermic needles. Large number of the patients opting for self-administration of drugs which would be possible using the needle free drug delivery devices. The adoption of the needle free drug delivery devices helps in reducing the healthcare expenses to the patients.

 

Market Dynamics: Needle Free Drug Delivery Market

Increase in the prevalence of chronic diseases such as hepatitis B, hepatitis C, AIDS etc. which drives the extensive use of injections and in turn helps in the needle free drug delivery market revenue growth. The growing necessity of self-administration and a significant growth of the geriatric population adding fuel for the growth of the needle free drug delivery market. The ease of administration and pain-free drug delivery and increasing focus on the portable delivery devices has boosted the market growth. However, the restricted use of the needle-free injection systems may hamper the growth of the needle free drug delivery market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/needle-free-drug-delivery-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Needle Free Drug Delivery Market

Needle free drug delivery market is segmented based on the technology, site of delivery, applications, and distribution channel

Based on the technology, the market is segmented into the following:

·         Jet Injectors

·         Inhaler Technology

·         Novel Needle Free Technologies

·         Transdermal Patch Technology

Based on the site of delivery, the market is segmented into the following:

·         Intradermal Injectors

·         Intramuscular Injectors

·         Subcutaneous Injectors

Based on the applications, the market is segmented into the following:

·         Pain Management

·         Insulin Delivery

·         Vaccine Delivery

·         Others

Based on the distribution channel, the market is segmented into the following:

·         Hospitals

·         Clinics

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/needle-free-drug-delivery-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Needle Free Drug Delivery Market

Geographically, global needle free drug delivery market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America needle free drug delivery market is accounted for significant owing to increase in the prevalence of chronic disorders. The adoption of the modern treatments is anticipated to drive the growth of the free drug delivery market. The Asia Pacific is expected to grow faster rate over the forecast period owing to the growing prevalence of chronic diseases and favorable patient demographics.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/needle-free-drug-delivery-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Needle Free Drug Delivery Market

Some of the players in the global needle free drug delivery market include:

·         Inovio Pharmaceuticals, Inc.(U.S)

·         3M Pharmaceuticals (U.S)

·         Antares Pharma, Inc. (U.S)

·         Crossject SA (France)

·         Becton Dickinson and Company (U.S)

·         MedImmune, Inc. (U.S)

·         Optinose, Inc. (U.S)

·         PharmaJet (U.S)

Notable Market Developments: Needle Free Drug Delivery Market

Ø  In February 2017, PharmaJet and Genexine collaborate on DNA vaccine development and commercialization of DNA vaccines for human applications using the PharmaJet needle-free injection systems

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/needle-free-drug-delivery-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
Global Gastric Cancer Testing Market - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024 Fri, 18 May 2018 11:41:43 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/479825.html http://content.comunicati.net/comunicati/turismo/last_minute/479825.html sravan sravan Global Gastric Cancer Testing Market - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Gastric Cancer Testing Market: By Test (Immunohistochemistry (IHC), Fluorescent in situ hybridization (FISH)), By Product (Kits and Reagents), By Gastric Cancer type (Adenocarcinoma, Lymphoma, Gastrointestinal stromal tumor (GIST), and Carcinoid Tumor), By End User (Hospitals, Diagnostic Centers, and Others), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global gastric cancer testing market was valued at US $ XX Mn and expected to grow at 5.0% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Gastric Cancer Testing Market

Cancer begins in the body when the cells in the body grow without any control. Cells present in any part of the body can develop cancer, which tend to spread to the other parts of the body. Gastric cancer is a type of cancer that starts in the stomach. The gastric cancer is also called as the stomach cancer. The progression of this cancer is slow. The advancement in the growth of the tumor leads serious complications. The treatment depends on the stage of the cancer. The early diagnosis helps in improving the survival rates.

 

Market Dynamics: Gastric Cancer Testing Market

Increase in the prevalence of gastrointestinal tumors, adenocarcinoma, lymphoma etc. and change in the lifestyles are majorly driving the growth of the gastric cancer testing market. Various factors such as increasing alcohol consumption and smoking is anticipated to drive the growth of the gastric cancer testing market. However, the stringent government regulations for the approval would hamper the growth of the market. The high cost involved in the testing would restrain the growth of the gastric cancer testing market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/gastric-cancer-testing-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Gastric Cancer Testing Market

Gastric cancer testing market is segmented based on the test, product, gastric cancer type and end user.

Based on the test, the market is segmented into the following:

·         Immunohistochemistry (IHC)

·         Fluorescent in situ hybridization (FISH)

 

Based on the product, the market is segmented into the following:

·         Kits

·         Reagents

 

Based on the gastric cancer type, the market is segmented into the following:

·         Adenocarcinoma

·         Lymphoma

·         Gastrointestinal stromal tumor (GIST)

·         Carcinoid tumor

 

Based on the end user, the market is segmented into the following:

·         Hospitals

·         Diagnostic centers

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/gastric-cancer-testing-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Gastric Cancer Testing Market

Geographically, global gastric cancer testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Asia Pacific gastric cancer testing market is the dominant market when compared with that of the other regional markets. According to the World Cancer Research Fund International, Japan has held the largest share of around 24.7% in the global stomach cancer treatment market owing to its higher consumption of the spicy and salty food. Also, the other countries such as China which accounted for about 29.9% and South Korea which accounted for 41.4% has higher rates of incidence in the stomach cancer. According to the World Health Organization (WHO), there are 723,000 cancer related deaths caused by the stomach cancer all across the globe. The North America and the European region are expected to grow at slow pace over the forecast period.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/gastric-cancer-testing-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Gastric Cancer Testing Market

Some of the players in the global gastric cancer testing market include:

·         Agilent Technologies, Inc. (U.S.)

·         Thermo Fisher Scientific, Inc. (U.S.)

·         Illumina, Inc. (Denmark)

·         Becton, Dickinson and Company (U.S.)

·         GE Healthcare (U.K.)

·         QIAGEN N.V.  (Netherlands)

·         Abbott Laboratories, Inc. (U.S.)

·         Roche Diagnostics (Switzerland)

·         Siemens Healthcare (Germany)

·         Philips Healthcare (U.K.)

·         C.R. Bard, Inc. (U.S.)

 

Notable Market Developments: Gastric Cancer Testing Market

Ø  In June 2016, Oxford Gene Technology (OGT) has launched extensive catalogue of fluorescence in situ hybridisation (FISH) products with 9 new Cytocell Aquarius probes which includes ETV6 Proximal Probe Green, ETV6 Distal Probe Red, MPO Probe Red, TP53 Probe Green, NUP214 Probe Red, DEK Probe Green, TAS2R1 (5p15.31) Probe Green, Chromosome 9 Satellite III Probe Aqua and Chromosome 15 Alpha Satellite Probe Red.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/gastric-cancer-testing-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>
ASISTENCIA FINANCIERA A PERSONAS HONESTAS Fri, 18 May 2018 10:52:27 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/479810.html http://content.comunicati.net/comunicati/turismo/last_minute/479810.html Buenos dias Debes tomar prestado de 2000 a 1,000. Buenos dias Debes tomar prestado de 2000 a 1,000. Buongiorno

 

È necessario prendere in prestito da 2000 a 1.000. 000 euro per la sua costruzione, il progetto immobiliare, la creazione della vostra azienda, riassemblare la vostra attività personale, volete fare e siete in difficoltà finanziarie, contattatemi via email, perché offro prestiti tra le persone in tutta sicurezza e fiducia al miglior prezzo 2% sicuro , affidabile ... Le migliori offerte Crediti rapidi e affidabili per i tuoi progetti. Risposta rapida:

 

email: edmundo.casar@gmail.com

edmundo.casar@gmail.com

]]>
Global Soft Tissue Allografts Market - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024 Wed, 16 May 2018 15:20:05 +0200 http://content.comunicati.net/comunicati/turismo/last_minute/479510.html http://content.comunicati.net/comunicati/turismo/last_minute/479510.html sravan sravan Global Soft Tissue Allografts Market - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Soft Tissue Allografts Market: By Soft Tissue Allografts Type (Cartilage Allografts, Dental Allografts, Tendon Allografts, Amniotic Allograft, Collagen Allograft, and Meniscus Allografts), By Application (Wound Care, Dentistry, and Orthopedic), By End User (Hospitals, Dental Clinics, Orthopedic Clinics, Ambulatory Surgical Centers), and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global soft tissue allografts market was valued at USD XX Mn in 2017 and expected to grow at 6.5% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Soft Tissue Allografts Market

Soft tissue allografts are the medical devices that act as an important substitute for the reconstruction of deficient ligaments, osteochondral defects that occur during knee surgery and torn menisci. The soft tissue allografts help obtaining a stable knee post-surgery. The reconstruction of the soft tissues using allografts reduces the surgical time and less donor tissue site morbidity.

 

Market Dynamics: Soft Tissue Allografts Market

Increase in the prevalence of degenerative joint diseases and chronic disorders such as diabetes are the key factor attributed for the growth of the soft tissue allografts market. The technological advancements and improving healthcare infrastructure are boosting the growth of the market. The mergers and acquisitions will help market vendors to tap ever growing market opportunities in the market. However, the high cost involved in the treatment procedure is hindering the growth of the soft tissue allografts market. The stringent government regulations are likely to hinder the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/soft-tissue-allografts-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Soft Tissue Allografts Market

Soft tissue allografts market is segmented based on the Soft tissue allografts type, application, and end user

 

Based on the Soft tissue allografts type, the market is segmented into the following:

·         Cartilage Allografts

o   Elastic Cartilage

o   Fibrocartilage

o   Hyaline Cartilage

 

·         Dental Allografts

o   Connective Tissue Graft

o   Pedicle Graft

o   Free Gingival Graft

 

·         Tendon Allografts

o   Tibialis

o   Achilles Tendon

o   Patellar Tendon

 

·         Amniotic Allograft

·         Collagen Allograft

·         Meniscus Allografts

 

Based on the application, the market is segmented into the following:

·         Wound Care

·         Dentistry

·         Orthopedic

 

o   Reconstruction

o   Spinal Surgeries

o   Sports Medicine

 

Based on the end user, the market is segmented into the following:

·         Hospitals

·         Dental Clinics

·         Orthopedic Clinics

·         Ambulatory Surgical Centers

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/soft-tissue-allografts-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Soft Tissue Allografts Market

Geographically, global soft tissue allografts market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America soft tissue allografts market growth driven by increase in the prevalence of diabetic foot ulcers. The deep-rooted healthcare infrastructure is enhancing the growth of the market in this region. The technological advancements, higher adoption of the modern treatment options, and growing awareness among the patient pool is also adding fuel for the growth of the market in North America region. The Europe and Asia Pacific are falling next to that of North American region. The Asia Pacific is expected to show significant growth over the forecasted period owing to developing healthcare sector in the emerging countries such as India, China and ASEAN countries.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/soft-tissue-allografts-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Soft Tissue Allografts Market

Some of the players in the global soft tissue allografts market include:

·         Allergen, Plc. (Ireland)

·         Alliqua BioMedical, Inc. (U.S)

·         Arthrex, Inc. (U.S)

·         C. R. Bard, Inc. (U.S)

·         Lattice Biologics Ltd. (U.S)

·         Zimmer Biomet (U.S)

·         Straumann Holding AG (Switzerland)

·         Alliqua BioMedical, Inc. (U.S)

·         MiMedix Group (U.S)

 

Notable Market Developments: Soft Tissue Allografts Market

Ø  In February 2017, Allergan plc has acquired LifeCell Corporation, a leading regenerative medicine company

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/soft-tissue-allografts-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

]]>